nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—S100B—melanoma	0.565	1	CbGaD
Pentamidine—CYP1A1—Dacarbazine—melanoma	0.0596	0.223	CbGbCtD
Pentamidine—CYP1A2—Carmustine—melanoma	0.044	0.164	CbGbCtD
Pentamidine—CYP1A2—Vemurafenib—melanoma	0.0348	0.13	CbGbCtD
Pentamidine—CYP3A4—Temozolomide—melanoma	0.0332	0.124	CbGbCtD
Pentamidine—CYP2D6—Vemurafenib—melanoma	0.0286	0.107	CbGbCtD
Pentamidine—CYP1A2—Dacarbazine—melanoma	0.0266	0.0996	CbGbCtD
Pentamidine—CYP3A4—Vemurafenib—melanoma	0.0182	0.0681	CbGbCtD
Pentamidine—CYP3A5—Docetaxel—melanoma	0.016	0.0599	CbGbCtD
Pentamidine—CYP3A4—Docetaxel—melanoma	0.00625	0.0234	CbGbCtD
Pentamidine—S100B—blood vessel—melanoma	0.00122	0.225	CbGeAlD
Pentamidine—S100B—eye—melanoma	0.00065	0.12	CbGeAlD
Pentamidine—S100B—retina—melanoma	0.000644	0.119	CbGeAlD
Pentamidine—AOC1—mammalian vulva—melanoma	0.000591	0.109	CbGeAlD
Pentamidine—S100B—skin of body—melanoma	0.000565	0.104	CbGeAlD
Pentamidine—CYP1A1—skin epidermis—melanoma	0.000394	0.0728	CbGeAlD
Pentamidine—S100B—head—melanoma	0.000369	0.0681	CbGeAlD
Pentamidine—AOC1—lymph node—melanoma	0.000296	0.0547	CbGeAlD
Pentamidine—Stomatitis—Dactinomycin—melanoma	0.00028	0.00292	CcSEcCtD
Pentamidine—Fatigue—Vemurafenib—melanoma	0.000279	0.00292	CcSEcCtD
Pentamidine—Constipation—Vemurafenib—melanoma	0.000277	0.00289	CcSEcCtD
Pentamidine—Pancytopenia—Temozolomide—melanoma	0.000277	0.00289	CcSEcCtD
Pentamidine—Lightheadedness—Docetaxel—melanoma	0.000276	0.00288	CcSEcCtD
Pentamidine—Hypoaesthesia—Bleomycin—melanoma	0.000275	0.00287	CcSEcCtD
Pentamidine—Neutropenia—Temozolomide—melanoma	0.000272	0.00284	CcSEcCtD
Pentamidine—Hyperglycaemia—Carmustine—melanoma	0.000272	0.00284	CcSEcCtD
Pentamidine—Sepsis—Docetaxel—melanoma	0.000268	0.0028	CcSEcCtD
Pentamidine—Renal failure—Carmustine—melanoma	0.000264	0.00276	CcSEcCtD
Pentamidine—Neuropathy peripheral—Carmustine—melanoma	0.000263	0.00275	CcSEcCtD
Pentamidine—Hyperglycaemia—Temozolomide—melanoma	0.000263	0.00274	CcSEcCtD
Pentamidine—Stomatitis—Carmustine—melanoma	0.000262	0.00273	CcSEcCtD
Pentamidine—Phlebitis—Docetaxel—melanoma	0.00026	0.00271	CcSEcCtD
Pentamidine—S100B—lymph node—melanoma	0.000258	0.0477	CbGeAlD
Pentamidine—Hepatitis—Dactinomycin—melanoma	0.000258	0.00269	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000258	0.00269	CcSEcCtD
Pentamidine—Flushing—Bleomycin—melanoma	0.000257	0.00268	CcSEcCtD
Pentamidine—Body temperature increased—Vemurafenib—melanoma	0.000256	0.00267	CcSEcCtD
Pentamidine—Pharyngitis—Dactinomycin—melanoma	0.000256	0.00267	CcSEcCtD
Pentamidine—Neuropathy peripheral—Temozolomide—melanoma	0.000255	0.00266	CcSEcCtD
Pentamidine—Stomatitis—Temozolomide—melanoma	0.000253	0.00264	CcSEcCtD
Pentamidine—Chills—Bleomycin—melanoma	0.000248	0.00259	CcSEcCtD
Pentamidine—Erythema multiforme—Dactinomycin—melanoma	0.000244	0.00254	CcSEcCtD
Pentamidine—Sinusitis—Temozolomide—melanoma	0.000244	0.00254	CcSEcCtD
Pentamidine—Erythema—Bleomycin—melanoma	0.000241	0.00251	CcSEcCtD
Pentamidine—Hypoaesthesia—Carmustine—melanoma	0.00024	0.00251	CcSEcCtD
Pentamidine—Hallucination—Carmustine—melanoma	0.00024	0.00251	CcSEcCtD
Pentamidine—Flushing—Dactinomycin—melanoma	0.000239	0.0025	CcSEcCtD
Pentamidine—Hypersensitivity—Vemurafenib—melanoma	0.000239	0.00249	CcSEcCtD
Pentamidine—Oedema peripheral—Carmustine—melanoma	0.000238	0.00248	CcSEcCtD
Pentamidine—Renal impairment—Docetaxel—melanoma	0.000236	0.00246	CcSEcCtD
Pentamidine—Hepatitis—Temozolomide—melanoma	0.000233	0.00243	CcSEcCtD
Pentamidine—Asthenia—Vemurafenib—melanoma	0.000233	0.00243	CcSEcCtD
Pentamidine—Hallucination—Temozolomide—melanoma	0.000232	0.00242	CcSEcCtD
Pentamidine—Hypoaesthesia—Temozolomide—melanoma	0.000232	0.00242	CcSEcCtD
Pentamidine—Pharyngitis—Temozolomide—melanoma	0.000231	0.00241	CcSEcCtD
Pentamidine—Chills—Dactinomycin—melanoma	0.000231	0.00241	CcSEcCtD
Pentamidine—Oedema peripheral—Temozolomide—melanoma	0.00023	0.0024	CcSEcCtD
Pentamidine—Pruritus—Vemurafenib—melanoma	0.000229	0.00239	CcSEcCtD
Pentamidine—Lethargy—Docetaxel—melanoma	0.000229	0.00239	CcSEcCtD
Pentamidine—Erythema—Dactinomycin—melanoma	0.000224	0.00234	CcSEcCtD
Pentamidine—Flushing—Carmustine—melanoma	0.000224	0.00234	CcSEcCtD
Pentamidine—Anaemia—Bleomycin—melanoma	0.000222	0.00232	CcSEcCtD
Pentamidine—Diarrhoea—Vemurafenib—melanoma	0.000222	0.00231	CcSEcCtD
Pentamidine—Erythema multiforme—Temozolomide—melanoma	0.00022	0.0023	CcSEcCtD
Pentamidine—Flushing—Temozolomide—melanoma	0.000216	0.00226	CcSEcCtD
Pentamidine—Arrhythmia—Carmustine—melanoma	0.000216	0.00225	CcSEcCtD
Pentamidine—Leukopenia—Bleomycin—melanoma	0.000215	0.00225	CcSEcCtD
Pentamidine—Dizziness—Vemurafenib—melanoma	0.000214	0.00224	CcSEcCtD
Pentamidine—Erythema—Carmustine—melanoma	0.00021	0.00219	CcSEcCtD
Pentamidine—Cough—Bleomycin—melanoma	0.00021	0.00219	CcSEcCtD
Pentamidine—Chills—Temozolomide—melanoma	0.000209	0.00218	CcSEcCtD
Pentamidine—Anaemia—Dactinomycin—melanoma	0.000207	0.00216	CcSEcCtD
Pentamidine—Liver function test abnormal—Docetaxel—melanoma	0.000207	0.00216	CcSEcCtD
Pentamidine—Vomiting—Vemurafenib—melanoma	0.000206	0.00215	CcSEcCtD
Pentamidine—Dry skin—Docetaxel—melanoma	0.000205	0.00214	CcSEcCtD
Pentamidine—Chest pain—Bleomycin—melanoma	0.000205	0.00214	CcSEcCtD
Pentamidine—Myalgia—Bleomycin—melanoma	0.000205	0.00214	CcSEcCtD
Pentamidine—Rash—Vemurafenib—melanoma	0.000204	0.00213	CcSEcCtD
Pentamidine—Dermatitis—Vemurafenib—melanoma	0.000204	0.00213	CcSEcCtD
Pentamidine—Headache—Vemurafenib—melanoma	0.000203	0.00212	CcSEcCtD
Pentamidine—Erythema—Temozolomide—melanoma	0.000203	0.00212	CcSEcCtD
Pentamidine—Discomfort—Bleomycin—melanoma	0.000202	0.00211	CcSEcCtD
Pentamidine—Leukopenia—Dactinomycin—melanoma	0.000201	0.0021	CcSEcCtD
Pentamidine—Dysgeusia—Temozolomide—melanoma	0.000199	0.00207	CcSEcCtD
Pentamidine—Confusional state—Bleomycin—melanoma	0.000198	0.00207	CcSEcCtD
Pentamidine—Vision blurred—Carmustine—melanoma	0.000198	0.00207	CcSEcCtD
Pentamidine—Tremor—Carmustine—melanoma	0.000197	0.00205	CcSEcCtD
Pentamidine—Anaphylactic shock—Bleomycin—melanoma	0.000196	0.00205	CcSEcCtD
Pentamidine—Infection—Bleomycin—melanoma	0.000195	0.00204	CcSEcCtD
Pentamidine—Anaemia—Carmustine—melanoma	0.000194	0.00203	CcSEcCtD
Pentamidine—Nausea—Vemurafenib—melanoma	0.000193	0.00201	CcSEcCtD
Pentamidine—Thrombocytopenia—Bleomycin—melanoma	0.000192	0.00201	CcSEcCtD
Pentamidine—Vision blurred—Temozolomide—melanoma	0.000191	0.002	CcSEcCtD
Pentamidine—Myalgia—Dactinomycin—melanoma	0.000191	0.00199	CcSEcCtD
Pentamidine—Bronchospasm—Docetaxel—melanoma	0.000191	0.00199	CcSEcCtD
Pentamidine—Tremor—Temozolomide—melanoma	0.00019	0.00198	CcSEcCtD
Pentamidine—Discomfort—Dactinomycin—melanoma	0.000189	0.00197	CcSEcCtD
Pentamidine—Leukopenia—Carmustine—melanoma	0.000188	0.00196	CcSEcCtD
Pentamidine—Anaemia—Temozolomide—melanoma	0.000188	0.00196	CcSEcCtD
Pentamidine—Anorexia—Bleomycin—melanoma	0.000187	0.00195	CcSEcCtD
Pentamidine—Angioedema—Temozolomide—melanoma	0.000185	0.00194	CcSEcCtD
Pentamidine—Pancytopenia—Docetaxel—melanoma	0.000184	0.00192	CcSEcCtD
Pentamidine—Hypotension—Bleomycin—melanoma	0.000184	0.00191	CcSEcCtD
Pentamidine—Vertigo—Temozolomide—melanoma	0.000182	0.0019	CcSEcCtD
Pentamidine—Convulsion—Carmustine—melanoma	0.000182	0.0019	CcSEcCtD
Pentamidine—Infection—Dactinomycin—melanoma	0.000182	0.0019	CcSEcCtD
Pentamidine—Leukopenia—Temozolomide—melanoma	0.000182	0.0019	CcSEcCtD
Pentamidine—Hypertension—Carmustine—melanoma	0.000181	0.00189	CcSEcCtD
Pentamidine—Neutropenia—Docetaxel—melanoma	0.000181	0.00189	CcSEcCtD
Pentamidine—Palpitations—Temozolomide—melanoma	0.000179	0.00187	CcSEcCtD
Pentamidine—Thrombocytopenia—Dactinomycin—melanoma	0.000179	0.00187	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000179	0.00187	CcSEcCtD
Pentamidine—Chest pain—Carmustine—melanoma	0.000179	0.00187	CcSEcCtD
Pentamidine—Myalgia—Carmustine—melanoma	0.000179	0.00187	CcSEcCtD
Pentamidine—Anxiety—Carmustine—melanoma	0.000178	0.00186	CcSEcCtD
Pentamidine—Cough—Temozolomide—melanoma	0.000177	0.00185	CcSEcCtD
Pentamidine—Paraesthesia—Bleomycin—melanoma	0.000176	0.00184	CcSEcCtD
Pentamidine—Convulsion—Temozolomide—melanoma	0.000176	0.00184	CcSEcCtD
Pentamidine—Hypertension—Temozolomide—melanoma	0.000175	0.00183	CcSEcCtD
Pentamidine—Dyspnoea—Bleomycin—melanoma	0.000175	0.00183	CcSEcCtD
Pentamidine—Anorexia—Dactinomycin—melanoma	0.000175	0.00182	CcSEcCtD
Pentamidine—Confusional state—Carmustine—melanoma	0.000173	0.0018	CcSEcCtD
Pentamidine—Myalgia—Temozolomide—melanoma	0.000173	0.0018	CcSEcCtD
Pentamidine—Arthralgia—Temozolomide—melanoma	0.000173	0.0018	CcSEcCtD
Pentamidine—Anxiety—Temozolomide—melanoma	0.000172	0.0018	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000171	0.00179	CcSEcCtD
Pentamidine—Discomfort—Temozolomide—melanoma	0.000171	0.00178	CcSEcCtD
Pentamidine—Decreased appetite—Bleomycin—melanoma	0.000171	0.00178	CcSEcCtD
Pentamidine—Infection—Carmustine—melanoma	0.00017	0.00178	CcSEcCtD
Pentamidine—Renal failure—Docetaxel—melanoma	0.00017	0.00177	CcSEcCtD
Pentamidine—Neuropathy peripheral—Docetaxel—melanoma	0.000169	0.00177	CcSEcCtD
Pentamidine—Dry mouth—Temozolomide—melanoma	0.000169	0.00176	CcSEcCtD
Pentamidine—Stomatitis—Docetaxel—melanoma	0.000168	0.00176	CcSEcCtD
Pentamidine—Pain—Bleomycin—melanoma	0.000168	0.00175	CcSEcCtD
Pentamidine—Conjunctivitis—Docetaxel—melanoma	0.000168	0.00175	CcSEcCtD
Pentamidine—Thrombocytopenia—Carmustine—melanoma	0.000168	0.00175	CcSEcCtD
Pentamidine—Tachycardia—Carmustine—melanoma	0.000167	0.00175	CcSEcCtD
Pentamidine—Confusional state—Temozolomide—melanoma	0.000167	0.00174	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000167	0.00174	CcSEcCtD
Pentamidine—Anaphylactic shock—Temozolomide—melanoma	0.000166	0.00173	CcSEcCtD
Pentamidine—Infection—Temozolomide—melanoma	0.000165	0.00172	CcSEcCtD
Pentamidine—Anorexia—Carmustine—melanoma	0.000163	0.00171	CcSEcCtD
Pentamidine—Thrombocytopenia—Temozolomide—melanoma	0.000162	0.00169	CcSEcCtD
Pentamidine—Feeling abnormal—Bleomycin—melanoma	0.000162	0.00169	CcSEcCtD
Pentamidine—Hypotension—Carmustine—melanoma	0.00016	0.00167	CcSEcCtD
Pentamidine—Decreased appetite—Dactinomycin—melanoma	0.000159	0.00166	CcSEcCtD
Pentamidine—Fatigue—Dactinomycin—melanoma	0.000158	0.00165	CcSEcCtD
Pentamidine—Anorexia—Temozolomide—melanoma	0.000158	0.00165	CcSEcCtD
Pentamidine—Pain—Dactinomycin—melanoma	0.000157	0.00163	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Carmustine—melanoma	0.000156	0.00163	CcSEcCtD
Pentamidine—Urticaria—Bleomycin—melanoma	0.000156	0.00163	CcSEcCtD
Pentamidine—Rhinitis—Docetaxel—melanoma	0.000155	0.00162	CcSEcCtD
Pentamidine—Body temperature increased—Bleomycin—melanoma	0.000155	0.00162	CcSEcCtD
Pentamidine—Hepatitis—Docetaxel—melanoma	0.000155	0.00162	CcSEcCtD
Pentamidine—Insomnia—Carmustine—melanoma	0.000155	0.00162	CcSEcCtD
Pentamidine—Hypoaesthesia—Docetaxel—melanoma	0.000154	0.00161	CcSEcCtD
Pentamidine—Paraesthesia—Carmustine—melanoma	0.000154	0.00161	CcSEcCtD
Pentamidine—Pharyngitis—Docetaxel—melanoma	0.000154	0.00161	CcSEcCtD
Pentamidine—Dyspnoea—Carmustine—melanoma	0.000153	0.00159	CcSEcCtD
Pentamidine—Oedema peripheral—Docetaxel—melanoma	0.000153	0.00159	CcSEcCtD
Pentamidine—Somnolence—Carmustine—melanoma	0.000152	0.00159	CcSEcCtD
Pentamidine—Feeling abnormal—Dactinomycin—melanoma	0.000151	0.00157	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000151	0.00157	CcSEcCtD
Pentamidine—Insomnia—Temozolomide—melanoma	0.00015	0.00156	CcSEcCtD
Pentamidine—Gastrointestinal pain—Dactinomycin—melanoma	0.00015	0.00156	CcSEcCtD
Pentamidine—Decreased appetite—Carmustine—melanoma	0.000149	0.00156	CcSEcCtD
Pentamidine—Paraesthesia—Temozolomide—melanoma	0.000149	0.00155	CcSEcCtD
Pentamidine—Dyspnoea—Temozolomide—melanoma	0.000148	0.00154	CcSEcCtD
Pentamidine—Somnolence—Temozolomide—melanoma	0.000147	0.00154	CcSEcCtD
Pentamidine—Erythema multiforme—Docetaxel—melanoma	0.000147	0.00153	CcSEcCtD
Pentamidine—Constipation—Carmustine—melanoma	0.000147	0.00153	CcSEcCtD
Pentamidine—Pain—Carmustine—melanoma	0.000147	0.00153	CcSEcCtD
Pentamidine—Dyspepsia—Temozolomide—melanoma	0.000146	0.00152	CcSEcCtD
Pentamidine—Body temperature increased—Dactinomycin—melanoma	0.000145	0.00151	CcSEcCtD
Pentamidine—Abdominal pain—Dactinomycin—melanoma	0.000145	0.00151	CcSEcCtD
Pentamidine—Hypersensitivity—Bleomycin—melanoma	0.000145	0.00151	CcSEcCtD
Pentamidine—Decreased appetite—Temozolomide—melanoma	0.000144	0.0015	CcSEcCtD
Pentamidine—Flushing—Docetaxel—melanoma	0.000144	0.0015	CcSEcCtD
Pentamidine—Fatigue—Temozolomide—melanoma	0.000143	0.00149	CcSEcCtD
Pentamidine—Pain—Temozolomide—melanoma	0.000142	0.00148	CcSEcCtD
Pentamidine—Constipation—Temozolomide—melanoma	0.000142	0.00148	CcSEcCtD
Pentamidine—Feeling abnormal—Carmustine—melanoma	0.000141	0.00147	CcSEcCtD
Pentamidine—Asthenia—Bleomycin—melanoma	0.000141	0.00147	CcSEcCtD
Pentamidine—Gastrointestinal pain—Carmustine—melanoma	0.00014	0.00146	CcSEcCtD
Pentamidine—Chills—Docetaxel—melanoma	0.000139	0.00145	CcSEcCtD
Pentamidine—Pruritus—Bleomycin—melanoma	0.000139	0.00145	CcSEcCtD
Pentamidine—Arrhythmia—Docetaxel—melanoma	0.000139	0.00145	CcSEcCtD
Pentamidine—Feeling abnormal—Temozolomide—melanoma	0.000137	0.00142	CcSEcCtD
Pentamidine—Abdominal pain—Carmustine—melanoma	0.000136	0.00141	CcSEcCtD
Pentamidine—Body temperature increased—Carmustine—melanoma	0.000136	0.00141	CcSEcCtD
Pentamidine—Gastrointestinal pain—Temozolomide—melanoma	0.000135	0.00141	CcSEcCtD
Pentamidine—Erythema—Docetaxel—melanoma	0.000135	0.00141	CcSEcCtD
Pentamidine—Hypersensitivity—Dactinomycin—melanoma	0.000135	0.00141	CcSEcCtD
Pentamidine—Dysgeusia—Docetaxel—melanoma	0.000132	0.00138	CcSEcCtD
Pentamidine—Urticaria—Temozolomide—melanoma	0.000132	0.00137	CcSEcCtD
Pentamidine—Asthenia—Dactinomycin—melanoma	0.000131	0.00137	CcSEcCtD
Pentamidine—Body temperature increased—Temozolomide—melanoma	0.000131	0.00137	CcSEcCtD
Pentamidine—Abdominal pain—Temozolomide—melanoma	0.000131	0.00137	CcSEcCtD
Pentamidine—Hypersensitivity—Carmustine—melanoma	0.000126	0.00132	CcSEcCtD
Pentamidine—Diarrhoea—Dactinomycin—melanoma	0.000125	0.00131	CcSEcCtD
Pentamidine—Vomiting—Bleomycin—melanoma	0.000125	0.0013	CcSEcCtD
Pentamidine—Anaemia—Docetaxel—melanoma	0.000125	0.0013	CcSEcCtD
Pentamidine—Rash—Bleomycin—melanoma	0.000124	0.00129	CcSEcCtD
Pentamidine—Dermatitis—Bleomycin—melanoma	0.000124	0.00129	CcSEcCtD
Pentamidine—Asthenia—Carmustine—melanoma	0.000123	0.00128	CcSEcCtD
Pentamidine—CYP1A1—skin of body—melanoma	0.000122	0.0226	CbGeAlD
Pentamidine—Hypersensitivity—Temozolomide—melanoma	0.000122	0.00127	CcSEcCtD
Pentamidine—Syncope—Docetaxel—melanoma	0.000121	0.00126	CcSEcCtD
Pentamidine—Leukopenia—Docetaxel—melanoma	0.000121	0.00126	CcSEcCtD
Pentamidine—Palpitations—Docetaxel—melanoma	0.000119	0.00124	CcSEcCtD
Pentamidine—Asthenia—Temozolomide—melanoma	0.000119	0.00124	CcSEcCtD
Pentamidine—Loss of consciousness—Docetaxel—melanoma	0.000119	0.00124	CcSEcCtD
Pentamidine—Cough—Docetaxel—melanoma	0.000118	0.00123	CcSEcCtD
Pentamidine—Diarrhoea—Carmustine—melanoma	0.000117	0.00122	CcSEcCtD
Pentamidine—Pruritus—Temozolomide—melanoma	0.000117	0.00122	CcSEcCtD
Pentamidine—Convulsion—Docetaxel—melanoma	0.000117	0.00122	CcSEcCtD
Pentamidine—Nausea—Bleomycin—melanoma	0.000117	0.00122	CcSEcCtD
Pentamidine—Hypertension—Docetaxel—melanoma	0.000117	0.00122	CcSEcCtD
Pentamidine—Vomiting—Dactinomycin—melanoma	0.000116	0.00122	CcSEcCtD
Pentamidine—Rash—Dactinomycin—melanoma	0.000115	0.00121	CcSEcCtD
Pentamidine—Chest pain—Docetaxel—melanoma	0.000115	0.0012	CcSEcCtD
Pentamidine—Arthralgia—Docetaxel—melanoma	0.000115	0.0012	CcSEcCtD
Pentamidine—Myalgia—Docetaxel—melanoma	0.000115	0.0012	CcSEcCtD
Pentamidine—Dizziness—Carmustine—melanoma	0.000113	0.00118	CcSEcCtD
Pentamidine—Diarrhoea—Temozolomide—melanoma	0.000113	0.00118	CcSEcCtD
Pentamidine—Dry mouth—Docetaxel—melanoma	0.000112	0.00117	CcSEcCtD
Pentamidine—CYP1A1—mammalian vulva—melanoma	0.000111	0.0206	CbGeAlD
Pentamidine—Confusional state—Docetaxel—melanoma	0.000111	0.00116	CcSEcCtD
Pentamidine—Anaphylactic shock—Docetaxel—melanoma	0.00011	0.00115	CcSEcCtD
Pentamidine—Dizziness—Temozolomide—melanoma	0.00011	0.00114	CcSEcCtD
Pentamidine—Infection—Docetaxel—melanoma	0.000109	0.00114	CcSEcCtD
Pentamidine—Vomiting—Carmustine—melanoma	0.000109	0.00114	CcSEcCtD
Pentamidine—Nausea—Dactinomycin—melanoma	0.000109	0.00114	CcSEcCtD
Pentamidine—Shock—Docetaxel—melanoma	0.000108	0.00113	CcSEcCtD
Pentamidine—Rash—Carmustine—melanoma	0.000108	0.00113	CcSEcCtD
Pentamidine—Dermatitis—Carmustine—melanoma	0.000108	0.00113	CcSEcCtD
Pentamidine—Thrombocytopenia—Docetaxel—melanoma	0.000108	0.00113	CcSEcCtD
Pentamidine—Tachycardia—Docetaxel—melanoma	0.000108	0.00112	CcSEcCtD
Pentamidine—Headache—Carmustine—melanoma	0.000107	0.00112	CcSEcCtD
Pentamidine—Vomiting—Temozolomide—melanoma	0.000105	0.0011	CcSEcCtD
Pentamidine—Anorexia—Docetaxel—melanoma	0.000105	0.0011	CcSEcCtD
Pentamidine—Rash—Temozolomide—melanoma	0.000104	0.00109	CcSEcCtD
Pentamidine—Dermatitis—Temozolomide—melanoma	0.000104	0.00109	CcSEcCtD
Pentamidine—Headache—Temozolomide—melanoma	0.000104	0.00108	CcSEcCtD
Pentamidine—Hypotension—Docetaxel—melanoma	0.000103	0.00107	CcSEcCtD
Pentamidine—Nausea—Carmustine—melanoma	0.000102	0.00106	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Docetaxel—melanoma	0.0001	0.00105	CcSEcCtD
Pentamidine—Insomnia—Docetaxel—melanoma	9.96e-05	0.00104	CcSEcCtD
Pentamidine—Paraesthesia—Docetaxel—melanoma	9.89e-05	0.00103	CcSEcCtD
Pentamidine—Nausea—Temozolomide—melanoma	9.84e-05	0.00103	CcSEcCtD
Pentamidine—Dyspnoea—Docetaxel—melanoma	9.82e-05	0.00102	CcSEcCtD
Pentamidine—Somnolence—Docetaxel—melanoma	9.79e-05	0.00102	CcSEcCtD
Pentamidine—Dyspepsia—Docetaxel—melanoma	9.7e-05	0.00101	CcSEcCtD
Pentamidine—Decreased appetite—Docetaxel—melanoma	9.58e-05	0.000999	CcSEcCtD
Pentamidine—Fatigue—Docetaxel—melanoma	9.5e-05	0.000991	CcSEcCtD
Pentamidine—Constipation—Docetaxel—melanoma	9.42e-05	0.000983	CcSEcCtD
Pentamidine—Pain—Docetaxel—melanoma	9.42e-05	0.000983	CcSEcCtD
Pentamidine—Feeling abnormal—Docetaxel—melanoma	9.08e-05	0.000947	CcSEcCtD
Pentamidine—Gastrointestinal pain—Docetaxel—melanoma	9.01e-05	0.00094	CcSEcCtD
Pentamidine—Body temperature increased—Docetaxel—melanoma	8.71e-05	0.000909	CcSEcCtD
Pentamidine—Abdominal pain—Docetaxel—melanoma	8.71e-05	0.000909	CcSEcCtD
Pentamidine—Hypersensitivity—Docetaxel—melanoma	8.12e-05	0.000847	CcSEcCtD
Pentamidine—CYP1A1—head—melanoma	7.97e-05	0.0147	CbGeAlD
Pentamidine—Asthenia—Docetaxel—melanoma	7.9e-05	0.000825	CcSEcCtD
Pentamidine—Pruritus—Docetaxel—melanoma	7.79e-05	0.000813	CcSEcCtD
Pentamidine—Diarrhoea—Docetaxel—melanoma	7.54e-05	0.000787	CcSEcCtD
Pentamidine—Dizziness—Docetaxel—melanoma	7.28e-05	0.00076	CcSEcCtD
Pentamidine—Vomiting—Docetaxel—melanoma	7e-05	0.000731	CcSEcCtD
Pentamidine—Rash—Docetaxel—melanoma	6.95e-05	0.000725	CcSEcCtD
Pentamidine—Dermatitis—Docetaxel—melanoma	6.94e-05	0.000724	CcSEcCtD
Pentamidine—Headache—Docetaxel—melanoma	6.9e-05	0.00072	CcSEcCtD
Pentamidine—Nausea—Docetaxel—melanoma	6.54e-05	0.000683	CcSEcCtD
Pentamidine—CYP2D6—head—melanoma	5.75e-05	0.0106	CbGeAlD
Pentamidine—CYP1A1—lymph node—melanoma	5.58e-05	0.0103	CbGeAlD
Pentamidine—CYP1A2—Metabolism—PLCB4—melanoma	9.79e-06	0.000146	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CASP3—melanoma	9.7e-06	0.000145	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2—melanoma	9.68e-06	0.000145	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	9.61e-06	0.000143	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.59e-06	0.000143	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PLA2G6—melanoma	9.58e-06	0.000143	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SDHD—melanoma	9.52e-06	0.000142	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CSPG4—melanoma	9.52e-06	0.000142	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—BSG—melanoma	9.52e-06	0.000142	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCND1—melanoma	9.44e-06	0.000141	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PHGDH—melanoma	9.42e-06	0.000141	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—LUM—melanoma	9.42e-06	0.000141	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CTNNB1—melanoma	9.35e-06	0.00014	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HPSE—melanoma	9.24e-06	0.000138	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GPAM—melanoma	9.22e-06	0.000138	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIP4K2A—melanoma	9.2e-06	0.000137	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC6A11—melanoma	9.2e-06	0.000137	CbGpPWpGaD
Pentamidine—S100B—Immune System—HRAS—melanoma	9.2e-06	0.000137	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MMP9—melanoma	9.16e-06	0.000137	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CG—melanoma	9.14e-06	0.000136	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CDKN1A—melanoma	9.13e-06	0.000136	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTEN—melanoma	9.11e-06	0.000136	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—VCAN—melanoma	9.11e-06	0.000136	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NFKB1—melanoma	9.07e-06	0.000135	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CUBN—melanoma	9.06e-06	0.000135	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTAP—melanoma	8.95e-06	0.000134	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PPARG—melanoma	8.82e-06	0.000132	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL6—melanoma	8.8e-06	0.000131	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PLA2G6—melanoma	8.78e-06	0.000131	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—BSG—melanoma	8.75e-06	0.000131	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CSPG4—melanoma	8.75e-06	0.000131	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SDHD—melanoma	8.75e-06	0.000131	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	8.75e-06	0.000131	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—VCAN—melanoma	8.6e-06	0.000128	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GPAM—melanoma	8.48e-06	0.000127	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—melanoma	8.23e-06	0.000123	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STAT3—melanoma	8.15e-06	0.000122	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.14e-06	0.000122	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NRAS—melanoma	8.13e-06	0.000121	CbGpPWpGaD
Pentamidine—S100B—Immune System—AKT1—melanoma	8.12e-06	0.000121	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CD—melanoma	8.04e-06	0.00012	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PHGDH—melanoma	7.98e-06	0.000119	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—LUM—melanoma	7.98e-06	0.000119	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ALB—melanoma	7.93e-06	0.000118	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—VCAN—melanoma	7.89e-06	0.000118	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.86e-06	0.000117	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PLA2G6—melanoma	7.84e-06	0.000117	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HPSE—melanoma	7.82e-06	0.000117	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MAPK3—melanoma	7.78e-06	0.000116	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP17A1—melanoma	7.68e-06	0.000115	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CUBN—melanoma	7.68e-06	0.000115	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—melanoma	7.57e-06	0.000113	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PLCB4—melanoma	7.55e-06	0.000113	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.47e-06	0.000111	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SDHD—melanoma	7.42e-06	0.000111	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—BSG—melanoma	7.42e-06	0.000111	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CSPG4—melanoma	7.42e-06	0.000111	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MAPK1—melanoma	7.41e-06	0.000111	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—melanoma	7.4e-06	0.000111	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP17A1—melanoma	7.26e-06	0.000108	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GNA11—melanoma	7.26e-06	0.000108	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PLA2G6—melanoma	7.21e-06	0.000108	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.21e-06	0.000108	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GPAM—melanoma	7.18e-06	0.000107	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.16e-06	0.000107	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC6A11—melanoma	7.1e-06	0.000106	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIP4K2A—melanoma	7.1e-06	0.000106	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—FASN—melanoma	7.1e-06	0.000106	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	7.07e-06	0.000106	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—VCAN—melanoma	7.04e-06	0.000105	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CB—melanoma	7e-06	0.000105	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KRAS—melanoma	6.99e-06	0.000104	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SLC5A5—melanoma	6.98e-06	0.000104	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGS2—melanoma	6.94e-06	0.000104	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTAP—melanoma	6.91e-06	0.000103	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GNA11—melanoma	6.86e-06	0.000102	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GNAQ—melanoma	6.75e-06	0.000101	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CD44—melanoma	6.75e-06	0.000101	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—FASN—melanoma	6.71e-06	0.0001	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.66e-06	9.95e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP17A1—melanoma	6.66e-06	9.94e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SLC5A5—melanoma	6.6e-06	9.85e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.56e-06	9.8e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	6.48e-06	9.67e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—VCAN—melanoma	6.48e-06	9.67e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP1B1—melanoma	6.47e-06	9.65e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.43e-06	9.6e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—melanoma	6.43e-06	9.59e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GNAQ—melanoma	6.37e-06	9.51e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CD44—melanoma	6.37e-06	9.51e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GNA11—melanoma	6.29e-06	9.38e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.24e-06	9.32e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—melanoma	6.22e-06	9.28e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.18e-06	9.23e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PHGDH—melanoma	6.16e-06	9.19e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LUM—melanoma	6.16e-06	9.19e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—FASN—melanoma	6.15e-06	9.18e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP1B1—melanoma	6.11e-06	9.12e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PLA2G6—melanoma	6.11e-06	9.12e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTEN—melanoma	6.05e-06	9.03e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SLC5A5—melanoma	6.05e-06	9.03e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HPSE—melanoma	6.04e-06	9.01e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—melanoma	5.95e-06	8.88e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP17A1—melanoma	5.94e-06	8.87e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CUBN—melanoma	5.93e-06	8.85e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.86e-06	8.75e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GNAQ—melanoma	5.84e-06	8.72e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CD44—melanoma	5.84e-06	8.72e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	5.78e-06	8.63e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SDHD—melanoma	5.72e-06	8.54e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CSPG4—melanoma	5.72e-06	8.54e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—BSG—melanoma	5.72e-06	8.54e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.72e-06	8.54e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL6—melanoma	5.69e-06	8.49e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.67e-06	8.46e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GNA11—melanoma	5.61e-06	8.37e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP1B1—melanoma	5.6e-06	8.36e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GPAM—melanoma	5.54e-06	8.28e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—FASN—melanoma	5.49e-06	8.2e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—VCAN—melanoma	5.49e-06	8.19e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP17A1—melanoma	5.46e-06	8.16e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC5A5—melanoma	5.4e-06	8.06e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.39e-06	8.05e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ABCB1—melanoma	5.33e-06	7.95e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—melanoma	5.25e-06	7.84e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GNAQ—melanoma	5.22e-06	7.79e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CD44—melanoma	5.22e-06	7.79e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.19e-06	7.75e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GNA11—melanoma	5.16e-06	7.7e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.11e-06	7.62e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.06e-06	7.55e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—FASN—melanoma	5.05e-06	7.54e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ABCB1—melanoma	5.03e-06	7.51e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.01e-06	7.48e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1B1—melanoma	5e-06	7.46e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC5A5—melanoma	4.97e-06	7.41e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.94e-06	7.38e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PRKCA—melanoma	4.9e-06	7.32e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ERCC2—melanoma	4.86e-06	7.26e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CD44—melanoma	4.8e-06	7.16e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GNAQ—melanoma	4.8e-06	7.16e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PLA2G6—melanoma	4.71e-06	7.04e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PRKCA—melanoma	4.63e-06	6.91e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP17A1—melanoma	4.63e-06	6.91e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ABCB1—melanoma	4.61e-06	6.89e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1B1—melanoma	4.6e-06	6.87e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ERCC2—melanoma	4.59e-06	6.86e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.57e-06	6.81e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	4.51e-06	6.73e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.41e-06	6.59e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GNA11—melanoma	4.37e-06	6.53e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—FASN—melanoma	4.28e-06	6.39e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—melanoma	4.27e-06	6.37e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PRKCA—melanoma	4.25e-06	6.34e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—VCAN—melanoma	4.23e-06	6.32e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ERCC2—melanoma	4.21e-06	6.29e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC5A5—melanoma	4.21e-06	6.28e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ABCB1—melanoma	4.12e-06	6.15e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GNAQ—melanoma	4.06e-06	6.07e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CD44—melanoma	4.06e-06	6.07e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.98e-06	5.94e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.94e-06	5.89e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP1B1—melanoma	3.9e-06	5.82e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—melanoma	3.84e-06	5.73e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.8e-06	5.68e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PRKCA—melanoma	3.79e-06	5.66e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ABCB1—melanoma	3.79e-06	5.65e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ERCC2—melanoma	3.76e-06	5.61e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARG—melanoma	3.71e-06	5.53e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—melanoma	3.63e-06	5.41e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP17A1—melanoma	3.57e-06	5.33e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARG—melanoma	3.5e-06	5.23e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.49e-06	5.21e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—melanoma	3.49e-06	5.21e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PRKCA—melanoma	3.49e-06	5.2e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ERCC2—melanoma	3.46e-06	5.16e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.44e-06	5.13e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CD—melanoma	3.38e-06	5.04e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GNA11—melanoma	3.37e-06	5.04e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALB—melanoma	3.33e-06	4.97e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—melanoma	3.33e-06	4.96e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—FASN—melanoma	3.3e-06	4.93e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC5A5—melanoma	3.25e-06	4.85e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARG—melanoma	3.21e-06	4.79e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCB1—melanoma	3.21e-06	4.79e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CD—melanoma	3.19e-06	4.76e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALB—melanoma	3.15e-06	4.7e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GNAQ—melanoma	3.14e-06	4.68e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CD44—melanoma	3.14e-06	4.68e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.11e-06	4.65e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1B1—melanoma	3.01e-06	4.49e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—melanoma	2.97e-06	4.43e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PRKCA—melanoma	2.95e-06	4.41e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CB—melanoma	2.94e-06	4.39e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ERCC2—melanoma	2.93e-06	4.37e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CD—melanoma	2.92e-06	4.36e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—melanoma	2.91e-06	4.35e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALB—melanoma	2.89e-06	4.31e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARG—melanoma	2.86e-06	4.28e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CB—melanoma	2.78e-06	4.15e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—melanoma	2.75e-06	4.11e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—melanoma	2.73e-06	4.08e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARG—melanoma	2.63e-06	3.93e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CD—melanoma	2.61e-06	3.9e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALB—melanoma	2.58e-06	3.85e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CB—melanoma	2.55e-06	3.8e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—melanoma	2.54e-06	3.79e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—melanoma	2.52e-06	3.77e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCB1—melanoma	2.48e-06	3.7e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.43e-06	3.62e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—melanoma	2.4e-06	3.59e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CD—melanoma	2.4e-06	3.58e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALB—melanoma	2.37e-06	3.54e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—melanoma	2.31e-06	3.45e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PRKCA—melanoma	2.28e-06	3.4e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CB—melanoma	2.27e-06	3.4e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ERCC2—melanoma	2.26e-06	3.37e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—melanoma	2.25e-06	3.36e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARG—melanoma	2.23e-06	3.33e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—melanoma	2.2e-06	3.29e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CB—melanoma	2.09e-06	3.12e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—melanoma	2.07e-06	3.09e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CD—melanoma	2.03e-06	3.04e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALB—melanoma	2.01e-06	3e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—melanoma	1.97e-06	2.93e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—melanoma	1.81e-06	2.7e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—melanoma	1.79e-06	2.68e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—melanoma	1.78e-06	2.66e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CB—melanoma	1.77e-06	2.65e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—melanoma	1.76e-06	2.62e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARG—melanoma	1.72e-06	2.57e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—melanoma	1.69e-06	2.53e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CD—melanoma	1.57e-06	2.34e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—melanoma	1.55e-06	2.32e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALB—melanoma	1.55e-06	2.31e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—melanoma	1.53e-06	2.29e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—melanoma	1.47e-06	2.19e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—melanoma	1.39e-06	2.07e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—melanoma	1.38e-06	2.07e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CB—melanoma	1.37e-06	2.04e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—melanoma	1.36e-06	2.02e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—melanoma	1.28e-06	1.9e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—melanoma	1.27e-06	1.89e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—melanoma	1.18e-06	1.76e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—melanoma	1.13e-06	1.69e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—melanoma	1.08e-06	1.61e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—melanoma	1.04e-06	1.56e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—melanoma	8.83e-07	1.32e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—melanoma	8.34e-07	1.24e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—melanoma	6.81e-07	1.02e-05	CbGpPWpGaD
